NO151746C - Analogifremgangsmaate for fremstilling av et terapeutisk aktivt penicillansyre-1,1-dioksyd - Google Patents

Analogifremgangsmaate for fremstilling av et terapeutisk aktivt penicillansyre-1,1-dioksyd

Info

Publication number
NO151746C
NO151746C NO781970A NO781970A NO151746C NO 151746 C NO151746 C NO 151746C NO 781970 A NO781970 A NO 781970A NO 781970 A NO781970 A NO 781970A NO 151746 C NO151746 C NO 151746C
Authority
NO
Norway
Prior art keywords
dioxyd
preparing
penicillanic acid
therapeutic active
analogue procedure
Prior art date
Application number
NO781970A
Other languages
English (en)
Norwegian (no)
Other versions
NO151746B (no
NO781970L (no
Inventor
Wayne Ernest Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO151746(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of NO781970L publication Critical patent/NO781970L/no
Publication of NO151746B publication Critical patent/NO151746B/no
Publication of NO151746C publication Critical patent/NO151746C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO781970A 1977-06-07 1978-06-06 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt penicillansyre-1,1-dioksyd NO151746C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (3)

Publication Number Publication Date
NO781970L NO781970L (no) 1978-12-08
NO151746B NO151746B (no) 1985-02-18
NO151746C true NO151746C (no) 1985-06-05

Family

ID=27122691

Family Applications (2)

Application Number Title Priority Date Filing Date
NO781970A NO151746C (no) 1977-06-07 1978-06-06 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt penicillansyre-1,1-dioksyd
NO823126A NO152448C (no) 1977-06-07 1982-09-15 Nye penicillansyre-l-oksyder for anvendelse som mellomprodukter ved fremstilling av penicillansyre-l, l-dioksyd

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO823126A NO152448C (no) 1977-06-07 1982-09-15 Nye penicillansyre-l-oksyder for anvendelse som mellomprodukter ved fremstilling av penicillansyre-l, l-dioksyd

Country Status (35)

Country Link
AR (1) AR224111A1 (US20100223739A1-20100909-C00025.png)
AT (2) AT360649B (US20100223739A1-20100909-C00025.png)
AU (1) AU513636B2 (US20100223739A1-20100909-C00025.png)
BE (1) BE867859A (US20100223739A1-20100909-C00025.png)
BG (2) BG34614A3 (US20100223739A1-20100909-C00025.png)
CH (1) CH634073A5 (US20100223739A1-20100909-C00025.png)
CS (1) CS208472B2 (US20100223739A1-20100909-C00025.png)
DD (2) DD148585A5 (US20100223739A1-20100909-C00025.png)
DE (2) DE2824535C3 (US20100223739A1-20100909-C00025.png)
DK (1) DK155740C (US20100223739A1-20100909-C00025.png)
EG (1) EG13869A (US20100223739A1-20100909-C00025.png)
FI (1) FI66003C (US20100223739A1-20100909-C00025.png)
FR (2) FR2393804A1 (US20100223739A1-20100909-C00025.png)
GB (1) GB2000138B (US20100223739A1-20100909-C00025.png)
GR (1) GR72255B (US20100223739A1-20100909-C00025.png)
HK (1) HK13184A (US20100223739A1-20100909-C00025.png)
HU (1) HU180042B (US20100223739A1-20100909-C00025.png)
IE (1) IE47079B1 (US20100223739A1-20100909-C00025.png)
IL (2) IL54867A (US20100223739A1-20100909-C00025.png)
IN (1) IN149747B (US20100223739A1-20100909-C00025.png)
IT (1) IT1096381B (US20100223739A1-20100909-C00025.png)
KE (1) KE3355A (US20100223739A1-20100909-C00025.png)
LU (1) LU79774A1 (US20100223739A1-20100909-C00025.png)
MY (1) MY8500092A (US20100223739A1-20100909-C00025.png)
NL (2) NL180009C (US20100223739A1-20100909-C00025.png)
NO (2) NO151746C (US20100223739A1-20100909-C00025.png)
NZ (1) NZ187476A (US20100223739A1-20100909-C00025.png)
OA (1) OA05964A (US20100223739A1-20100909-C00025.png)
PH (3) PH26810A (US20100223739A1-20100909-C00025.png)
PL (1) PL114501B1 (US20100223739A1-20100909-C00025.png)
PT (1) PT68146A (US20100223739A1-20100909-C00025.png)
SE (2) SE436206B (US20100223739A1-20100909-C00025.png)
SG (1) SG65383G (US20100223739A1-20100909-C00025.png)
SU (1) SU860706A1 (US20100223739A1-20100909-C00025.png)
YU (1) YU41829B (US20100223739A1-20100909-C00025.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (US20100223739A1-20100909-C00025.png) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IL59948A0 (en) * 1979-05-21 1980-06-30 Rech Applications Therap Penicillanic acid derivatives,their production and pharmaceutical compositions containing them
DE3051044C2 (US20100223739A1-20100909-C00025.png) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3780112T2 (de) * 1986-04-10 1992-12-24 Leo Pharm Prod Ltd Verfahren zur herstellung von penicillansaeure-derivaten.
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (US20100223739A1-20100909-C00025.png) * 1977-05-09 1979-01-18
JPS5439090A (en) * 1977-07-13 1979-03-24 Glaxo Group Ltd Betaalactam compound and its preparation

Also Published As

Publication number Publication date
MY8500092A (en) 1985-12-31
YU41829B (en) 1988-02-29
SG65383G (en) 1985-03-29
FR2393805B1 (US20100223739A1-20100909-C00025.png) 1984-02-24
CH634073A5 (en) 1983-01-14
PL207396A1 (pl) 1979-06-04
NO152448C (no) 1985-10-02
DD140888A5 (de) 1980-04-02
HK13184A (en) 1984-02-24
ATA128580A (de) 1981-02-15
NO152448B (no) 1985-06-24
KE3355A (en) 1983-12-16
NL180009C (nl) 1986-12-16
PT68146A (en) 1978-07-01
DE2857263B2 (de) 1981-04-23
FI66003C (fi) 1984-08-10
IT7824270A0 (it) 1978-06-06
PL114501B1 (en) 1981-02-28
ATA411278A (de) 1980-06-15
BE867859A (fr) 1978-12-06
OA05964A (fr) 1981-06-30
SE8305916D0 (sv) 1983-10-27
FR2393804A1 (fr) 1979-01-05
IT1096381B (it) 1985-08-26
IE47079B1 (en) 1983-12-14
DE2857263C3 (de) 1981-12-17
GR72255B (US20100223739A1-20100909-C00025.png) 1983-10-06
BG34614A3 (en) 1983-10-15
AU513636B2 (en) 1980-12-11
YU117078A (en) 1983-01-21
NO151746B (no) 1985-02-18
NZ187476A (en) 1982-08-17
FI781800A (fi) 1978-12-08
PH16465A (en) 1983-10-20
IL54867A (en) 1981-11-30
AT364084B (de) 1981-09-25
SE436206B (sv) 1984-11-19
AU3683878A (en) 1979-12-06
DD148585A5 (de) 1981-06-03
IL62168A0 (en) 1981-03-31
NO781970L (no) 1978-12-08
NL930064I1 (nl) 1993-09-01
IE781140L (en) 1978-12-07
AR224111A1 (es) 1981-10-30
GB2000138A (en) 1979-01-04
NL7806126A (nl) 1978-12-11
BG34615A3 (en) 1983-10-15
DE2824535C3 (de) 1981-01-22
SE447995B (sv) 1987-01-12
DE2824535B2 (de) 1980-05-14
FI66003B (fi) 1984-04-30
CS208472B2 (en) 1981-09-15
EG13869A (en) 1983-03-31
DK155740C (da) 1989-10-23
FR2393804B1 (US20100223739A1-20100909-C00025.png) 1980-11-07
SE8305916L (sv) 1983-10-27
HU180042B (en) 1983-01-28
PH21116A (en) 1987-07-16
PH26810A (en) 1992-11-05
AT360649B (de) 1981-01-26
DK155740B (da) 1989-05-08
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
SE7806628L (sv) 1978-12-08
LU79774A1 (fr) 1980-01-22
IN149747B (US20100223739A1-20100909-C00025.png) 1982-04-03
GB2000138B (en) 1982-03-03
SU860706A1 (ru) 1981-08-30
NO823126L (no) 1978-12-08
DE2824535A1 (de) 1978-12-14
NL930064I2 (nl) 1994-04-18
IL54867A0 (en) 1978-08-31

Similar Documents

Publication Publication Date Title
NO151746C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt penicillansyre-1,1-dioksyd
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
BE879918A (fr) Distributeur de medicament
SE7808485L (sv) Forfarande for framstellning av oligoimider
SE7804397L (sv) Forfarande for framstellning av en tetradekapeptid
SE7804474L (sv) Forfarande for bestenkning av foremal
DK22978A (da) Laegemiddelsproejte
NO161000C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv penemkarboksylsyre eller -ester.
NO820290L (no) Mellomprodukter for fremstilling av terapeutisk aktive antrakinon-derivater.
SE7807240L (sv) Forfarande for framstellning av para-bensokinon
FI781866A (fi) Foerfarande foer framstaellning av terapeutiskt aktiv n-/3-merkaptoacetylamino) bensoyl/ glycin.
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO152510C (no) Analogifremgangsmaate til fremstilling av en terapeutisk virksomm 7beta-(d-2-amino-2-(3-c1-c4-alkyl-sulfonylaminofenyl)-acetylamino)-3-r-3-cefem-4-karboksylsyre
NO149471C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
SE7707707L (sv) Ett nytt forfarande for framstellning av en terapeutiskt aktiv forening
NO147601C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin
NO151861C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-substituert-10,11-dihydro-5h-dibenzo-(a,d)-cyclohepten-5,10-iminer
SE7803456L (sv) Forfarande for framstellning av en farmaceutisk komposition
NO152873C (no) Analogifremgangsmaate til fremstilling av en terapeutisk aktiv oktahydro-1h-pyrrolo(2,3-g)isokinoliner.
NO145135C (no) Analogifremgangsmaate ved fremstilling av den terapeutisk aktive forbindelse 3-cyan-n-(n,n-diemtylaminopropyl)-iminodibenzyl
NO145436C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminer.
SE7707708L (sv) En ny mellanprodukt for framstellning av terapeutiskt aktiva foreningar
NO151323C (no) Analogifremgangsmaate til fremstilling av et terapeutisk aktivt n-(2-tienyl)-2-okso-2,3-dihydro-benzo(b)tiofen-3-karboksamid
NO145161C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt o-nitrofenyl-tionokarbamoylkarbaminat